Julien Lazarovici Selected Research

Julien Lazarovici Research Topics

17	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 12/2015
12	Neoplasms (Cancer) 10/2021 - 11/2017
9	Lymphoma (Lymphomas) 01/2021 - 11/2015
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 08/2017
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021 - 11/2018
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 08/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 01/2019
2	Neutropenia 01/2019 - 08/2017
1	Fatigue 04/2021
1	Frailty 04/2021
1	Sepsis (Septicemia) 04/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Cytopenia 01/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2019
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2019
1	Herpes Zoster 01/2019
1	Infections 01/2019
1	Infertility (Sterility) 01/2019
1	Pancytopenia 01/2019
1	Pure Red-Cell Aplasia 01/2019
1	Febrile Neutropenia 01/2019
1	Bone Marrow Failure Disorders 01/2017
1	Eosinophilia 01/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 07/2016
1	Organizing Pneumonia 07/2016
1	Lung Injury 07/2016
1	Pneumonia (Pneumonitis) 07/2016
1	T-Cell Lymphoma (Lymphoma, T Cell) 11/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2015
1	Heart Failure 04/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2015
1	Myocardial Infarction 04/2015

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 04/2015
4	Etoposide (VP 16)FDA LinkGeneric 04/2021 - 11/2015
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2020 - 04/2015
3	Brentuximab VedotinIBA 01/2022 - 06/2018
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 07/2016
3	AntibodiesIBA 01/2019 - 01/2017
3	Prednisone (Sone)FDA LinkGeneric 01/2019 - 04/2015
3	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
3	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 04/2015
2	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2021
2	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2019
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 01/2019
2	Rituximab (Mabthera)FDA Link 04/2021 - 08/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2021 - 11/2015
2	pembrolizumabIBA 01/2021 - 01/2019
2	LigandsIBA 01/2019 - 01/2017
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2018
1	Biological ProductsIBA 10/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2021
1	B7-H1 AntigenIBA 01/2021
1	CD20 AntigensIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Heme (Haem)IBA 01/2019
1	Procarbazine (Matulane)FDA Link 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 11/2018
1	Carmustine (FIVB)FDA Link 11/2018
1	AlbuminsIBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 08/2017
1	NivolumabIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2016
1	SteroidsIBA 11/2015
1	PlatinumIBA 11/2015
1	Histone Deacetylase InhibitorsIBA 04/2015
1	romidepsin (FK228)FDA Link 04/2015

11	Therapeutics 10/2021 - 04/2015
11	Drug Therapy (Chemotherapy) 04/2021 - 11/2015
5	Radiotherapy 01/2020 - 11/2015
4	Immunotherapy 10/2021 - 11/2017
3	Stem Cell Transplantation 01/2022 - 06/2018
2	Investigational Therapies (Experimental Therapy) 10/2021 - 10/2021
2	Immunomodulation 01/2018 - 01/2018
1	Cell Transplantation 01/2017
1	Homologous Transplantation 01/2017